Original articleEfficacy of Short-term Postoperative Perfluoro-n-octane Tamponade for Pediatric Complex Retinal Detachment
Section snippets
Methods
The multicenter study was performed in accordance with the tenets of the Declaration of Helsinki. The Institutional Review Board of the Naha City Hospital and Sakai Hospital Kinki University Faculty of Medicine approved this prospective study before the beginning of the study, and a written informed consent was obtained from the parents of all patients. The protocol of this study was in compliance with Health Insurance Portability and Accountability Act requirements.
A perfluoro-n-octane
Case Report 1
Case 1 was an 8-year-old boy who was referred to us for the treatment of a rhegmatogenous RD involving the macula of the right eye. Fundus examinations revealed a retinal break in the inferior temporal retina of the right eye and a peripheral avascular area with fibrovascular membranes in the temporal retina in both eyes. These findings suggested that the patient had FEVR in both eyes. The decimal best-corrected visual acuity (BCVA) was 0.04 in the right eye. The retina was reattached by
Discussion
Postoperative perfluoro-n-octane tamponade was used for a short period in 10 eyes with pediatric complex RD, in which gas or silicone oil had been considered to be ineffective because the posterior proliferative changes were in the inferior retina. Perfluoro-n-octane tamponade was used because we believed that it would be difficult for children to maintain a prone position for any length of time. The perfluoro-n-octane was left in all of the eyes for 1 to 4 weeks, and the retinas remained
Ayako Imaizumi, MD, completed her residency in Ophthalmology at Osaka University Hospital. Currently she is the director of ophthalmology at Naha City Hospital and a postgraduate student at Graduate School of Medicine, University of the Ryukyus. Her field of interest includes surgical treatment of vitreoretinal disease such as diabetic retinopathy, retinal detachment, and retinopathy of prematurity.
References (14)
- et al.
Peripheral nonperfusion and tractional retinal detachment associated with congenital optic nerve anomalies
Ophthalmology
(2013) - et al.
Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane
Ophthalmology
(2002) - et al.
Pediatric vs adult retinal detachment
Eye
(2007) - et al.
Effect of silicone oil on experimental traction retinal detachment
Arch Ophthalmol
(1987) - et al.
Fibroblast behavior at aqueous interfaces with perfluorocarbon, silicone and fluorosilicone liquids
Invest Ophthalmol Vis Sci
(1990) - et al.
Management of giant retinal tears using perfluorodecaline as a postoperative short-term vitreoretinal tamponade: a long-term follow-up study
Ophthalmic Surg
(1994) - et al.
Vitrectomy with short-term postoperative tamponade using perfluorocarbon liquid for giant retinal tears
Br J Ophthalmol
(2005)
Cited by (19)
Recurrent proliferative vitreoretinopathy in a patient with morning glory syndrome and intellectual disability
2022, American Journal of Ophthalmology Case ReportsCitation Excerpt :A third surgery was performed in which peripheral retinotomy and peeling of the proliferative membrane under perfluoro-n-octane (PFO) were followed by laser ablation on the peripheral retina to avoid the recurrent RD (Fig. 2B). PFO was retained to achieve better apposition of the retina and underlying RPE without maintaining face-down position.15 IOL was removed in the third surgery because of the severe PVR and fibrin formation on both anterior and posterior surfaces of the IOL.
Retinal detachment repair with perfluoro-N-octane endotamponade in an infant with juvenile X-linked retinoschisis
2020, American Journal of Ophthalmology Case ReportsCitation Excerpt :Given that these changes occurred in the inferior retina, and similar histological changes occurred in the superior retina of rabbit eyes injected with silicone oil, it was postulated that these effects may be mechanical rather than toxic. In their series, Imaizumi and colleagues noted no adverse effects in eyes receiving PFO tamponade for periods between 1 and 5 weeks.6 The appropriate duration for retained PFO, therefore, seems to be 1–2 weeks.
Bilateral rhegmatogenous retinal detachments from giant retinal tears in an infant with abusive head trauma and Stickler syndrome
2020, American Journal of Ophthalmology Case ReportsCitation Excerpt :The rate of anatomical success of retinal detachment surgery in pediatric cases is etiology-dependent with rhegmatogenous retinal detachments having better outcomes compared to tractional retinal detachments.11 The use of PFCL for short-term postoperative tamponade for retinal detachment in the pediatric population has previously been described in complex retinal detachment cases.13 PFCL was advantageous compared to silicone oil or gas tamponade in this infant as it allowed for supine positioning and eliminated the difficulty of prone positioning.
Autologous Retinal Transplant for Refractory Macular Holes: Multicenter International Collaborative Study Group
2019, OphthalmologyCitation Excerpt :We also did not observe any cases of PFC toxicity, elevated intraocular pressure, intraocular inflammation (early or delayed), or flap displacement after PFC removal. Short-term use of intraocular PFC has been shown to be relatively safe.43–47 We observed late development of cystoid macular edema–like changes in the graft in several cases, usually 4 to 6 months after surgery.
Pediatric rhegmatogenous retinal detachment: A meta-Analysis of clinical features, surgical success rate, and prognostic factors
2023, Indian Journal of Ophthalmology
Ayako Imaizumi, MD, completed her residency in Ophthalmology at Osaka University Hospital. Currently she is the director of ophthalmology at Naha City Hospital and a postgraduate student at Graduate School of Medicine, University of the Ryukyus. Her field of interest includes surgical treatment of vitreoretinal disease such as diabetic retinopathy, retinal detachment, and retinopathy of prematurity.
Shunji Kusaka, MD is a Professor of Ophthalmology at Sakai Hospital Kinki University Faculty of Medicine, Sakai, Japan. Dr Kusaka completed his residency in Ophthalmology at Osaka University and his fellowship training in vitreoretinal surgery at Osaka National Hospital. After finishing research fellowship program at University of Michigan, he continues clinical research in vitreoretinal diseases in Japan. His research interests include treatment of various vitreoretinal disorders, especially pediatric retinal diseases.